FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc., expanding the regulatory approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Hypothyroidism

Drugs mentioned

• TIROSINT (Levothyroxine Sodium)

Snippet

SUPPL AP for TIROSINT (LEVOTHYROXINE SODIUM)